DCF — RAPPAHANNOCK GENERAL HOSPITAL
Enterprise Value: $-113.2M
🛡️ Public data only — no PHI permitted on this instance.
← DashboardPRFProfileMEMIC MemoBRGBridgeCIComp IntelSCNScenariosAIMLDCFDCFLBOLBOFIN3-StmtMKTMarketDENDenialRETReturnsLVRLeversWFLWaterfallPLYPlaybookTRDTrendsPREDPredictedMEM2Memo
$-113.2M
Enterprise Value
$-34.9M
PV of Cash Flows
$-78.3M
PV of Terminal Value
$-126.1M
Terminal Value
10.0%
WACC
2.5%
Terminal Growth
Cash Flow Projections
PROJ| Year | Revenue | EBITDA | Margin | FCF | PV(FCF) |
|---|---|---|---|---|---|
| Year 1 | $43.4M | $-7.6M | -17.0% | $-9.4M | $-8.5M |
| Year 2 | $44.7M | $-7.3M | -16.0% | $-9.2M | $-7.6M |
| Year 3 | $46.1M | $-7.1M | -15.0% | $-9.0M | $-6.8M |
| Year 4 | $47.5M | $-7.1M | -15.0% | $-9.1M | $-6.2M |
| Year 5 | $48.9M | $-7.2M | -15.0% | $-9.2M | $-5.7M |
Interpretation
INTAt a WACC of 10.0% and terminal growth of 2.5%, enterprise value is $-113.2M. Terminal value accounts for 0% of total EV — consider sensitivity to terminal assumptions.
Next steps: Check the LBO model to see equity returns at this entry price, or the EBITDA bridge to model value creation levers.
Assumptions
ASSMrevenue base$42.2M
revenue growth rates[0.03, 0.03, 0.03, 0.03, 0.03]
ebitda margin base-0.1789939267547349
ebitda margin improvement bps[50, 100, 100, 50, 25]
capex pct revenue0.04
nwc pct revenue0.08
tax rate0.25
projection years5